| Nov 14 |
Mersana Therapeutics Inc (MRSN) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
|
| Nov 14 |
Q3 2024 Mersana Therapeutics Inc Earnings Call
|
| Nov 13 |
Mersana Therapeutics, Inc. (MRSN) Q3 2024 Earnings Call Transcript
|
| Nov 13 |
Mersana Therapeutics, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 13 |
Mersana Therapeutics, Inc. (MRSN) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 13 |
Mersana Therapeutics GAAP EPS of -$0.09 beats by $0.08, revenue of $12.6M beats by $5.04M
|
| Nov 13 |
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results
|
| Nov 13 |
Earnings Scheduled For November 13, 2024
|
| Nov 12 |
Mersana Therapeutics Q3 2024 Earnings Preview
|
| Nov 6 |
Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024
|
